Vistagen Completes Phase 3 Study for Social Anxiety Treatment
Vistagen, a late-stage clinical biopharmaceutical company focused on neuroscience and developing intranasal therapies called pherines, announced that the final patient has completed the randomized, double-blind, placebo-controlled portion of the...
